Tag Archives: Removing Regulatory Barriers

Mental Health Research: Official Framework (Department of Health)

Posted on December 9, 2017 by Dementia and Elderly Care News

Summary The Department of Health has published a framework covering intended mental health research in the UK over the next decade. This is another response to recommendations in the independent Mental Health Taskforce’s Five Year Forward View for Mental Health … Continue reading →

Posted in Commissioning, Community Care, Department of Health, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, Mental Health, National, NHS, NHS England, Non-Pharmacological Treatments, Patient Care Pathway, Quick Insights, Standards, UK, Universal Interest | Tagged 5YFV: NHS Five Year Forward View, 5YFVMH, 5YFVMH Taskforce, A&E Psychiatric Patients, Access and Choice, Access to Mental Health Services, Acute And Crisis Care, Adult Mental Health Care Clusters, Adult Mental Health Services (AMHS), Adult Mental Health: Common Mental Health Problems, Adult Mental Health: Community, Adult Psychiatric Morbidity Survey (APMS) in England, Alternative Care Settings, Barriers, Barriers to Early Diagnosis, Barriers to Engagement, Barriers to Innovation, Barriers to Involvement, Bureaucratic and Regulatory Burdens, Capacity Building, Care Planning, Care Planning (Community), Care Planning (Inpatient), Child and Adolescent Mental Health Services, Child and Adolescent Mental Health Services (CAMHS) Transformation Plans, Children and Young People’s Mental Health, Choice of Treatments, Clinical Record Interactive Search (CRIS), Cognitive Behavioural Therapy (CBT), Common Mental Health Problems (CMHP), Costs of Mental Health Problems at Work, Costs of Mental Health Problems in UK, Data Informatics and Virtual Populations, Dementia Clinical Record Interactive Search (D-CRIS), Emerging Interventions and Alternative Care Settings, Five Year Forward View for Mental Health (5YFVMH), Flexible Funding, Health Inequalities and Socio-Economic Inequalities in Health, Health Informatics, Hospital Discharge Delays, IAPT: Improving Access to Psychological Therapies, Implementing the Mental Health Forward View, Improving Access to Mental Health Services, Improving Access to Psychological Therapy (IAPT), Improving Perinatal Mental Health, Independent Mental Health Taskforce to the NHS in England, Industry Engagement, Informatics, Integrating Mental and Physical Healthcare, Life-Course Approach to Healthy and Active Ageing, Life-Course Approach to Mental Health, Measures of Social Support, Mental and Physical Health, Mental Health and Illness, Mental Health Capacity Building, Mental Health Crisis, Mental Health Crisis Care, Mental Health Crisis Care Concordat, Mental Health Liaison Services in Emergency Departments and Inpatient Ward, Mental Health Problems, Mental Health Professionals in Emergency Departments, Mental Health Research, Mental Health Research Funding, Mental Health Service Budgets, Mental Health Services, Mental Health Services in Accident and Emergency Units, Mental Health Support in Schools, Mental Health Support in the Workplace, Mental Health Taskforce, Mental Health Taskforce Report, Mental Health Trusts, More Flexible Funding Systems (Facilitators of Innovation), National Information Board (Initially Known as the Informatics Services Commissioning Group), Parity Between Mental and Physical Health, Parity of Esteem, Patient Involvement in Research, Paul Farmer: Chair of Mental Health Taskforce, Perinatal Mental Health, Personalised Care Planning, Physical Health of People With Mental Health Problems, Post-Traumatic Stress Disorder, Prevention and Stigma, Public Involvement in Research, Reducing the Divide Between Mental and Physical Healthcare, Reduction in Bureaucracy, Removing Regulatory Barriers, Research Priority Setting in Mental Health, Roadmap for Mental Health Research in Europe (ROAMER) Programme, Science and Informatics, Social Support, Social Support / Community Networks, Socio-Economic Drivers of Health Inequality, Socio-Economic Patterning, Technology and Informatics, Translational Research, Virtual Populations, Waiting Times for Mental Health Services, Workforce and Skill Mix, Young People’s Mental Health Services | Leave a comment

NHS Leadership Review (BBC News / Department of Health)

Posted on August 6, 2015 by Dementia and Elderly Care News

Summary Lord Rose, formerly of Marks & Spencer, was commissioned by the Secretary of State for Health to review leadership in the NHS. This controversial and independent report covers how to attract and develop capable leaders, whether from inside or … Continue reading →

Monitor and Trust Development Authority Under Single Leadership: Delivering Better Support to Hospitals (Department of Health / Monitor)

Posted on June 12, 2015 by Dementia and Elderly Care News

Summary Closer working between Monitor and the NHS Trust Development Authority (NHS TDA) should help reduce lack of standardisation and inconsistency, and help to embed hospital patient safety as an NHS priority. All NHS hospitals, whether foundation trusts or non-foundation … Continue reading →

International Meeting of Regulators on Challenges of Dementia Research and Drug Development (MHRA / Department of Health)

Posted on May 26, 2015 by Dementia and Elderly Care News

Summary The Medicines and Healthcare Products Regulatory Agency (MHRA) took part in an international workshop with other regulators, and has released a statement of intent about how to support the development of drugs for dementia. This work is in support … Continue reading →

Posted in Department of Health, For Doctors (mostly), For Researchers (mostly), International, Pharmacological Treatments, Quick Insights, World Health Organization (WHO) | Tagged Accelerating Alzheimer's Research and Drug Development, Attrition Analysis, Bill and Melinda Gates Foundation, Clinical Trial Efficiency, Composite End Points: Development of Standardised and Validated Endpoint Components, Coordinated Regulatory Action, Danish Health and Medicines Authority, Dementia Research, Department of Health’s Integrated Development Initiative, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Drug Development for Alzheimer's Disease, Drug Regulation, Drug-Development Pipeline, European Medicines Agency, Expediting Regulatory Approval Procedures: Balancing Benefits and Risks, Federal Institute for Drugs and Medical Devices, First Global Ministerial Conference on Global Action Against Dementia, First WHO Ministerial Conference on Global Action Against Dementia, G7 Global Dementia Summit, G8 Dementia Summit, Global Alzheimer’s and Dementia Action Alliance (GADAA), Global Leadership, Global Ministerial Conference on Global Action Against Dementia (WHO), Global Outlook, Global Regulatory Efficiency and Consistency, Health Canada, Incentives, Incentives for Drug Development, International Federation of Pharmaceutical Manufacturers and Associations, Italian Medicines Agency, Market Failure (Dementia Research and Drug Development), Medicines and Healthcare Products Regulatory Agency, Medicines and Healthcare Products Regulatory Agency (MHRA), Medicines Evaluation Board, Multilateral Cooperation: Reducing Unnecessary Testing Replication and Methodology Testing, Office for Life Sciences, Pharmaceutical and Medicines Devices Agency (Japan), Pharmaceutical Regulators, Raj Long: Senior Regulatory Officer for Integrated Development in Global Health at the Bill & Melinda Gates Foundation, Regulation, Regulators, Regulatory Barriers, Regulatory Research Dementia Workshop, Regulatory System, Removing Regulatory Barriers, Research and Innovation, Resource and Incentives, Swissmedic, Translational Research, US Food and Drug Administration, WDC: World Dementia Council, WHO: World Health Organization, World Dementia Council | Leave a comment

Second Global Dementia Legacy Event: Ottawa, September 11th/12th 2014 (Department of Health / Dementia Challenge / World Dementia Council / CIHR / AVIESAN)

Posted on September 11, 2014 by Dementia and Elderly Care News

Summary Canada and France are co-hosting the second Global Action Against Dementia Legacy Event in Ottawa (Canada) on September 11th – 12th 2014. This event will explore how to take advantage of partnership working and collaboration between industry and academia, … Continue reading →

Posted in Acute Hospitals, Community Care, Department of Health, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Integrated Care, International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Pharmacological Treatments, Quick Insights, Standards, Universal Interest | Tagged Academia-Industry Partnerships, Academia-Industry Synergies, Academic-Industry Collaborations, Alain Beaudet: President of Canadian Institutes of Health Research (CIHR), Alice Wong: Minister of State (Seniors) in Canada, Alzheimer Society of Canada, AVIESAN: French National Alliance for Life Sciences and Health, •Alzheimer Society of Canada, Big Data, Biotechnology, Canada, Canada's Research Strategy for Alzheimer's Disease, Canada-France Legacy Event, Canadian Institutes of Health Research (CIHR), Challenge on Dementia, Challenge on Dementia (David Cameron), Collaboration, Collaborative Projects, Cross-Sector Partnerships, Dementia Challenge, Dementia in Canada, Dementia Innovation, Dementia Research, Dementia Time-Bomb, Dennis Gillings: Former World Dementia Envoy, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies for Dementia, Drug Development for Alzheimer's Disease, Drug Discovery Programme, Drug Identification, Drug-Development Pipeline, Faye Forbes (Living With Dementia), France, Free Open Access Journals, G7 Global Dementia Summit, G8 Dementia Summit, G8 Dementia Summit Agreements, G8 Summit on Dementia Communique, G8 Summit on Dementia Declaration, Global Action Against Dementia, Global Context, Global Dementia Legacy Event, Global Dementia Legacy Event on Academia-Industry Synergies, Global Leadership, Global Outlook, Incentives and Investment, Incentives for Drug Development, Innovation, Innovative Medicines Initiative, Institute of Health and Medical Research (Inserm), International Collaborations, International Programmes, Japan Legacy Event, Knowledge Networks, Knowledge Translation, Massachusetts Biotech Cluster: CONNECT, Matthew Dineen (Carer), Medical Devices, Networks, Networks and Alliances, Neurological Research, OECD Big Data and Sustainability Initiative for Large-Scale Research on Dementia, Open Access, Open Access Databases, Open Access Journals, Open Access Knowledge Resources, Open Access Research, Partnership, Partnership and Collaboration, Partnership Working, Payment Systems and Incentives, Pharmaceutical Industry, Pharmacological Research, Philippe Zeller: Ambassador of France to Canada, Prime Minister's Challenge on Dementia, Prime Minister’s Dementia Challenge, Regulatory Barriers: Regulatory Environment, Removing Regulatory Barriers, Research and Innovation, Research Networks, Resource and Incentives, Second Global Dementia Legacy Event, Second Global Dementia Legacy Event (Ottawa: September 2014), The Honourable Rona Ambrose: Minister of Health (Canada), UK Legacy Event, USA Legacy Event, Venture Capital (Approach to Research), World Dementia Council, Yves Lévy: French National Institute of Health and Medical Research (Inserm) and Chairman of Aviesan (French National Alliance for Life Sciences and Health Care) | Leave a comment

CQC and LGO Help People Raise Concerns About Adult Social Care (CQC / LGO)

Posted on May 18, 2014 by Dementia and Elderly Care News

Summary The Care Quality Commission (CQC) and the Local Government Ombudsman have announced an arrangement which makes it easier for people to raise concerns about adult social care in England. New processes transfer enquiries between these organisations, thereby saving people’s … Continue reading →

Posted in Community Care, CQC: Care Quality Commission, For Carers (mostly), For Social Workers (mostly), In the News, Local Interest, National, Practical Advice, Quick Insights, Standards, UK, Universal Interest | Tagged Adult Social Care, Adult Social Care in England, Adult Social Care Provision (CQC), Adult Social Care Services, Andrea Sutcliffe: Chief Inspector of Adult Social Care, Barriers to Involvement, Barriers to Speaking Out About Poor Care, Care Quality Commission (CQC), Data Sharing, Data Sharing Agreement, Information Sharing, LGO: Local Government Ombudsman, Local Government Ombudsman, Organisational and Cultural Barriers, Overcoming Barriers, Raising Concerns, Regulators Sharing Information, Removing Regulatory Barriers, Sharing Knowledge and Information, Social Care Concerns | Leave a comment

Balancing Quality and Finance (NHS Confederation)

Posted on April 27, 2014 by Dementia and Elderly Care News

Summary This NHS Confederation briefing summarises a round table discussion about how NHS might achieve the best balance between the need to control or reduce costs and the aim of providing better care. This briefing was produced in partnership with … Continue reading →

Posted in Commissioning, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, National, NHS Alliance, NHS Confederation, Quick Insights, Standards, UK, Universal Interest | Tagged Academy of Medical Royal Colleges, Achieving Better Value, Balancing Quality and Finance, Barriers and Enablers to Value in Healthcare, Best Value Duty, Better Value, Blame Culture, Cancer Drugs Fund (CDF), Care Quality, Collaboration, Collaborative Working, Commissioning for Value, Cost–Benefit Analyses, Culture Change, Culture of Candour, Delivering Quality and Value, Disempowering Environments, Duty of Best Value, Economic Sustainability, End to Silo Working, Expensive Drugs, Faculty of Medical Leadership and Management, Finance, Financial Constraints, Financial Context, Financial Pressure in the NHS, Financial Pressures, Financial Sustainability in the NHS, Funding, Health Funding, Healthcare Financial Management Association (HFMA), HFMA: Healthcare Financial Management Association, High Quality Care for All, High Quality Commissioning, Holistic Quality Improvement, Honesty, Internal Distrust: Working Together, Kadcyla, Lack of Direction, Local Commissioning, Misaligned Funding Mechanisms, NHS Culture, NHS Finances, NHS Financial Leadership, NHS Funding, NHS Funding Gap, NHS Leadership, NHS Quality, NHS: a Political Football, Openness and Transparency, Partnership and Collaboration, Patient and Public Engagement (PPE), Payment and Funding Systems, Political Candour, Quality and Sustainability, Quality Improvement, Quality in the NHS, Quality Payments in the NHS, Quality: Outcomes, Reducing Spending on Expensive Drugs, Regulatory Barriers, Removing Regulatory Barriers, Resistance to Change, Shared System Leadership, Sustainability, Sustainable Funding, Sustainable Health and Social Care, System Leadership, Transparency, Transparency and Accountability, Transparency and Public Trust, Unresponsive Culture, Value Across Public Services, Value for Money, Value Improvement, Value Opportunities, Value Opportunities in Local Commissioning, Whole Service Approaches, Whole System Integration, Whole System Performance, Whole Systems Design, Working Together for Change | Leave a comment

Tag Archives: Removing Regulatory Barriers

International Meeting of Regulators on Challenges of Dementia Research and Drug Development (MHRA / Department of Health)

Second Global Dementia Legacy Event: Ottawa, September 11th/12th 2014 (Department of Health / Dementia Challenge / World Dementia Council / CIHR / AVIESAN)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites